drugset / Trial / NCT01355133
Safety and Efficacy Study of Intrasphincteric Autologous Myoblast Injection to Treat Stress Urinary Incontinence
Phase 1/2
Completed
40 enrolled
University Medical Centre Ljubljana
Innovacell Biotechnologie AG · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this pilot clinical study is to determine if intrasphincteric autologous myoblast injections in combination with electrical stimulation are safe and effective in treating stress urinary incontinence, confirming the optimal dose and assessing tolerability of the procedure.
Timeline
- Start
- 2009-08
- Primary completion
- 2011-02
- Completion
- 2011-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | autologous myoblasts | Cell therapy | 1e+06 cells | Other |
| Subject | autologous myoblasts | Cell therapy | 5e+07 cells | Other |